Pharmaceutical formulations of GHRH molecules

Details for Australian Patent Application No. 2008235215 (hide)

Owner Theratechnologies Inc.

Inventors Loughrey, Helen; Chang, Byeong

Agent Cullen & Co

Pub. Number AU-A-2008235215

PCT Pub. Number WO2008/122118

Priority 60/909,985 04.04.07 US

Filing date 4 April 2008

Wipo publication date 16 October 2008

International Classifications

A61K 38/25 (2006.01) Medicinal preparations containing peptides - Growth hormone-releasing factor (GH-RF) (Somatoliberin)

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

Event Publications

1 October 2009 PCT application entered the National Phase

  PCT publication WO2008/122118 Priority application(s): WO2008/122118

24 February 2011 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 22 Dec 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008235219-Apparatus and methodology for comminuting materials

2008235212-Inhibitors of histone deacetylase